Last reviewed · How we verify
restricted opioid prescribing
Restricted opioid prescribing is a clinical policy and practice guideline that limits the use of opioid medications to reduce the risk of addiction, overdose, and adverse outcomes.
Restricted opioid prescribing is a clinical policy and practice guideline that limits the use of opioid medications to reduce the risk of addiction, overdose, and adverse outcomes. Used for Reduction of opioid-related adverse events and addiction risk in military healthcare settings, Chronic and acute pain management with non-opioid alternatives.
At a glance
| Generic name | restricted opioid prescribing |
|---|---|
| Sponsor | Walter Reed National Military Medical Center |
| Modality | Small molecule |
| Therapeutic area | Pain Management / Public Health Policy |
| Phase | FDA-approved |
Mechanism of action
This is not a drug but rather a prescribing protocol and institutional policy implemented at Walter Reed National Military Medical Center to minimize opioid exposure and dependence. It involves evidence-based guidelines for appropriate opioid use, dose limitations, and preference for non-opioid or multimodal pain management strategies. The approach aims to balance pain control with public health concerns regarding opioid-related harms.
Approved indications
- Reduction of opioid-related adverse events and addiction risk in military healthcare settings
- Chronic and acute pain management with non-opioid alternatives
Common side effects
Key clinical trials
- ACT Therapy for HF Migraine (NA)
- Patient Satisfaction With Opioid Restriction After Urogynecologic Surgery (PHASE4)
- Opioid Use in Shoulder Arthroplasty Patients: A Stratification and Algorithm (NA)
- Liberal vs. Restricted Post-discharge Opioid Prescribing Following Midurethral Sling (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: